CureGenetics
About:
Cure Genetics is a biotechnology company that develops innovative medicines & molecular diagnostics to treat cancers & genetic diseases.
Website: http://www.curegenetics.com/
Top Investors: Qiming Venture Partners, Oriza Holdings, CTS Capital, Qingsong Fund, Advantech Capital
Description:
Cure Genetics is a biotechnology company developing cutting-edge applications of technologies in innovative medicines and molecular diagnostics for the next-generation treatment of cancers and genetic diseases.
Total Funding Amount:
$95.5M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Suzhou, Jiangsu, China
Founded Date:
2016-01-01
Contact Email:
info(AT)curegenetics.com
Founders:
Yuanyuan Xu
Number of Employees:
51-100
Last Funding Date:
2024-03-28
IPO Status:
Private
Industries:
© 2025 bioDAO.ai